How a young Canadian entrepreneur is poised to improve the lives of women
Global News
Suffering from debilitating menstrual cramps herself, Nanette Sene made it her mission to help others by creating a wearable device to alleviate period pain.
Every month, for roughly 40 years of their lives, women will get their period.
For the majority of women, menstruation can mean several days of pain and discomfort, ranging from simple annoyance to all-out debilitation.
The most common symptom according to the Cleveland Clinic is cramping, which is caused by contractions as the uterus sheds its lining.
Nanette Sene, cofounder and CEO of Montreal startup Juno Technologies, knows a thing or two about period pain.
“To me, it (feels) a bit like I was being stabbed,” she said of her own menstrual cramps. “It’s a sharp pain that continuously comes and goes, comes and goes.”
The pain is unpredictable, Sene said, in that she doesn’t necessarily know when it’s going to start in her cycle and how long it will last from one time to the next.
With Juno, Sene has made it her mission to help other women by creating a wearable device to alleviate pain.
Sene said the wireless device is rechargeable, easy to use and fits discreetly under clothing.
Three cancer types — lung, stomach and cervical cancer — accounted for nearly half of all preventable cancer cases in both men and women globally, a new study has found.
The former CEO of the IWK Health Centre has been sentenced to nine months in jail for defrauding the children's hospital during her time in charge.
Consuming raw dairy products can expose people to a variety of illnesses including avian influenza, brucella, tuberculosis, Salmonella, and E. coli, among other pathogens.
Oceans North, a non-profit environmental group, says western Hudson Bay is home to about one-quarter of the world's beluga whale population.
Perhaps one of the best embodiments of Canadians' ability to embrace winter, rather than hide from it, pops up every December at the confluence of the Red and Assiniboine rivers.
Nipah virus has a death rate ranging from 45 to 75 per cent, and there is no vaccine or medical treatment available for animals or humans.